InvestorsHub Logo
Followers 2
Posts 105
Boards Moderated 0
Alias Born 10/18/2019

Re: Bio_pete post# 9249

Thursday, 10/24/2019 2:35:46 PM

Thursday, October 24, 2019 2:35:46 PM

Post# of 17454
Pete, on the contrary, this trial will have better numbers simply because you will have more Hispanic and Black patients, and those are known that they don't respond well to current SoC. actually there was 5 Black patients in the AURA trial in the Placebo arm and they all showed NR. not to mention that the Steroid dose used in the AURORA trial is so low that the MMF arm response will be lower than the other LN trials going on with other companies. No trial has reduced the steroid to the level that AUPH is doing ( without any impact in the VCS arm efficacy, but definitely impacting the Placebo arm efficacy)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News